GENinCode (LON:GENI) Stock Price Up 16.2% – Here’s What Happened

Shares of GENinCode Plc (LON:GENI) traded up 16.2% during trading on Tuesday. The stock traded as high as GBX 0.70 and last traded at GBX 0.70. 3,865,641 shares were traded during trading, a decline of 21% from the average session volume of 4,872,882 shares. The stock had previously closed at GBX 0.60.

GENinCode Stock Performance

The company has a market cap of £5.25 million, a PE ratio of -0.55 and a beta of 0.59. The business’s 50-day moving average is GBX 0.84 and its 200 day moving average is GBX 0.95. The company has a debt-to-equity ratio of 4.75, a quick ratio of 15.88 and a current ratio of 2.22.

GENinCode (LON:GENI) last posted its quarterly earnings results on Tuesday, September 29th. The company reported GBX (0.38) earnings per share for the quarter. GENinCode had a negative return on equity of 481.34% and a negative net margin of 202.42%. On average, equities research analysts predict that GENinCode Plc will post -7.13 EPS for the current fiscal year.

GENinCode Company Profile

GENinCode Plc is a UK based company specialising in genetic risk assessment of cardiovascular disease. Cardiovascular disease is the leading cause of death and disability worldwide.

GENinCode operates business units in the UK, in the United States through GENinCode U.S. Inc and in Europe through GENinCode S.L.U.

GENinCode predictive technology provides patients and physicians with globally leading preventative care and treatment strategies. GENinCode CE marked invitro-diagnostic molecular tests combine clinical algorithms and bioinformatics to provide advanced patient risk assessment to predict disease onset.